Dirk W Grijpma
Overview
Explore the profile of Dirk W Grijpma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
131
Citations
2476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bagnol R, Siverino C, Barnier V, OMahony L, Grijpma D, Eglin D, et al.
Biomacromolecules
. 2023 Nov;
24(12):5589-5604.
PMID: 37983925
Immunoregulatory polysaccharides from probiotic bacteria have potential in biomedical engineering. Here, a negatively charged exopolysaccharide from with confirmed immunoregulatory activity (EPS624) was applied in multilayered polyelectrolyte coatings with positively charged...
2.
van Bochove B, Rongen J, Hannink G, Seppala J, Poot A, Grijpma D
Macromol Biosci
. 2023 Nov;
24(3):e2300364.
PMID: 37923394
Three-armed poly(trimethylene carbonate) (PTMC) and poly(trimethylene carbonate-co-Ɛ-caprolactone) (P(TMC-co-ε-CL)) macromers with molecular weights of approximately 30 kg mol are synthesized by ring-opening polymerization and subsequent functionalization with methacrylic anhydride. Networks are...
3.
Liang J, Wang Z, Poot A, Grijpma D, Dijkstra P, Wang R
Int J Bioprint
. 2023 Jul;
9(5):750.
PMID: 37457933
Methacrylated gelatin (GelMA) has been intensively studied as a 3D printable scaffold material in tissue regeneration fields, which can be attributed to its well-known biological functions. However, the long-term stability...
4.
Gielen A, Ankone M, Grijpma D, Poot A
Biomacromolecules
. 2022 Nov;
24(10):4366-4374.
PMID: 36416797
To improve the mechanical performance of hyaluronic acid (HA)-based hydrogels, we prepared novel hybrid hydrogels consisting of hydrophilic HA and hydrophobic poly(trimethylene carbonate) (PTMC). Both polymers were functionalized with methacrylic...
5.
Gareb B, van Bakelen N, Driessen L, Buma P, Kuipers J, Grijpma D, et al.
Bioact Mater
. 2022 Apr;
17:439-456.
PMID: 35386449
Applying biodegradable osteosyntheses avoids the disadvantages of titanium osteosyntheses. However, foreign-body reactions remain a major concern and evidence of complete resorption is lacking. This study compared the physico-chemical properties, histological...
6.
Petta D, Grijpma D, Alini M, Eglin D, DEste M
ACS Biomater Sci Eng
. 2021 Jan;
4(8):3088-3098.
PMID: 33435028
Biofabrication via three-dimensional printing (3DP) is expanding our capabilities of producing tissue engineering constructs for regenerative medicine, personalized medicine, and engineered tissue models of disease and diagnostics. Hydrogel-based materials for...
7.
Rotman S, Sumrall E, Ziadlou R, Grijpma D, Richards R, Eglin D, et al.
Front Microbiol
. 2020 Oct;
11:538060.
PMID: 33072008
As viruses with high specificity for their bacterial hosts, bacteriophages (phages) are an attractive means to eradicate bacteria, and their potential has been recognized by a broad range of industries....
8.
Rotman S, Moriarty T, Nottelet B, Grijpma D, Eglin D, Guillaume O
Pharmaceutics
. 2020 Sep;
12(9).
PMID: 32957602
Bone infection is a feared complication for patients with surgically fixed bone fractures and local antibiotic delivery is important in prophylaxis and treatment of these infections. Recent studies indicated that...
9.
Blanquer S, Grijpma D
Methods Mol Biol
. 2020 Aug;
2147:19-30.
PMID: 32840807
A new generation of sophisticated tissue engineering scaffolds are developed using the periodicity of trigonometric equations to generate triply periodic minimal surfaces (TPMS). TPMS architectures display minimal surface energy that...
10.
Rotman S, Thompson K, Grijpma D, Richards R, Moriarty T, Eglin D, et al.
J Orthop Translat
. 2020 Apr;
21:136-145.
PMID: 32309139
Objective: Bone infections are challenging to treat because of limited capability of systemic antibiotics to accumulate at the bone site. To enhance therapeutic action, systemic treatments are commonly combined with...